MYC and neoplasm: To further investigate whether the levels of MYC expression in tumor cells correlate with the growth inhibitory response, we utilized GI50 data from the NCI-60 diverse human tumor cell line panel available for MYCMI-6 by the Developmental Therapeutics Program of the U.S. National Cancer Institute (DTP-NCI), extracted from the NIH-supported CellMinerTM version 2.1 (https://discover.nci.nih.gov/cellminer).